Loading…
Harrow, Inc. is projected to rise to $52.06 by 2027, a +34% move from its current price of $38.77. HROW is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $37.70 | $38.80 | $39.93 | +0.07% |
| Aug 3 | $37.28 | $38.83 | $40.44 | +0.14% |
| Aug 4 | $36.96 | $38.85 | $40.84 | +0.22% |
| Aug 5 | $36.71 | $38.88 | $41.19 | +0.29% |
| Aug 6 | $36.48 | $38.91 | $41.50 | +0.36% |
| Aug 7 | $36.29 | $38.94 | $41.78 | +0.44% |
| Aug 8 | $36.11 | $38.97 | $42.05 | +0.51% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $36.11 | $38.97 | $42.05 | +0.51% |
| Week 2 | $35.16 | $39.17 | $43.62 | +1.02% |
| Week 3 | $34.50 | $39.36 | $44.92 | +1.53% |
| Week 4 | $33.97 | $39.56 | $46.08 | +2.05% |
| Week 5 | $33.54 | $39.77 | $47.15 | +2.57% |
| Week 6 | $33.16 | $39.97 | $48.17 | +3.09% |
| Week 7 | $32.84 | $40.17 | $49.14 | +3.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Harrow, Inc. is a healthcare company focused on ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments and offers ImprimisRx, an ophthalmology-focused compounded medication portfolio along with a broad range of eye care products.
The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.
Harrow, Inc. (HROW) is currently priced at $38.45, with a market cap of $1.43B, and it is ranked 2138.
The stock’s sentiment is NEUTRAL, with RSI14 at 50. Its near-term moving averages are SMA50 at $38.39 and SMA200 at $41.15, framing a largely sideways tape near the current price.
The 30-day trading range spans from $32.27 to $45.81, with near-term support at $35.90 and resistance at $46.65. The multi-year forecast projects a bullish trajectory, with the avg price rising from $38.45 in 2026 to $109.46 by 2030 and ultimately to $861.35 by 2050, accompanied by substantial ROIs up to 2140.2% over the period.
A major floor 25.1% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 20.3% above — a clean break opens room to run.
A major ceiling 29.4% above — clearing it would confirm fresh momentum.
Key HROW support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HROW market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $38.63 | Buy | $39.13 | Sell |
| MA 10 | $40.45 | Sell | $40.08 | Sell |
| MA 20 | $42.18 | Sell | $40.88 | Sell |
| MA 50 | $39.37 | Sell | $40.24 | Sell |
| MA 100 | $37.94 | Buy | $39.89 | Sell |
| MA 200 | $41.11 | Sell | $39.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.91 | Neutral |
| Stoch RSI (14) | 17.61 | Buy |
| CCI (20) | -99.05 | Neutral |
| Williams %R (14) | -85.75 | Info |
| MACD (12,26,9) | -0.75 | Sell |
| ROC (12) | -9.69 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 14.25 | Buy |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | -3.26 | Sell |
| Ultimate (7,14,28) | 32.75 | Neutral |
| Momentum (10) | -7.88 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 38.13 | Buy |
| ADX (14) | 18.40 | Neutral |
| ATR (14) | 1.13 | Info |
The 30-day picture is neutral in tone.
RSI14 sits at 50, with SMA50 at $38.39 and SMA200 at $41.15, suggesting limited directional pressure in the near term.
The 30-day range is $32.27–$45.81, with near-term support at $35.90 and resistance at $46.65.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.03 | $38.77 | $53.80 | 0% | Neutral | |
| $41.31 | $52.06 | $69.48 | +34% | Bullish | |
| $52.18 | $67.76 | $94.07 | +75% | Bullish | |
| $62.61 | $83.34 | $119.30 | +115% | Bullish | |
| $75.76 | $103.08 | $151.37 | +166% | Bullish | |
| $82.25 | $114.15 | $171.42 | +194% | Bullish | |
| $81.56 | $115.31 | $176.64 | +197% | Bullish | |
| $94.40 | $135.81 | $211.83 | +250% | Bullish | |
| $106.63 | $155.96 | $247.33 | +302% | Bullish | |
| $128.66 | $191.19 | $307.90 | +393% | Bullish | |
| $168.84 | $269.64 | $463.07 | +595% | Bullish | |
| $393.51 | $711.97 | $1,342.25 | +17.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $29.03 | $38.77 | $45.92 | +0.00% |
| September 2026 | $33.61 | $39.83 | $48.58 | +2.72% |
| October 2026 | $34.70 | $41.42 | $51.09 | +4.00% |
| November 2026 | $34.58 | $41.52 | $51.67 | +0.24% |
| December 2026 | $35.52 | $42.87 | $53.80 | +3.27% |
Click any year to see its month-by-month HROW forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Harrow, Inc.'s 2026 outlook centres on $38.77, within a $29.03 to $53.80 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, HROW could reach as high as $69.48, with a base case around $52.06 and support toward $41.31 — roughly +34% from $38.77. Momentum favours further upside here.
Expect HROW to range from $52.18 to $94.07 through 2028. The $67.76 average target implies a +75% move from current prices. That is up +30% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The HROW price prediction for 2029 points to an average of $83.34 (low $62.61, high $119.30) — a potential gain of +115% on today's $38.77. Momentum favours further upside here.
In 2030, HROW is projected to trade between $75.76 and $151.37, averaging $103.08 — a potential gain of +166% from today's $38.77. That is up +24% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Harrow, Inc.'s 2031 outlook centres on $114.15, within a $82.25 to $171.42 range. That is up +11% on the projected 2030 average. That marks a +194% change versus current levels. Momentum favours further upside here.
By 2032, HROW could reach as high as $176.64, with a base case around $115.31 and support toward $81.56 — roughly +197% from $38.77. Buyers look set to stay in control over this stretch.
Expect HROW to range from $94.40 to $211.83 through 2033. The $135.81 average target implies a +250% move from current prices. That is up +18% on the projected 2032 average. Momentum favours further upside here.
The HROW price prediction for 2034 points to an average of $155.96 (low $106.63, high $247.33) — a potential gain of +302% on today's $38.77. Buyers look set to stay in control over this stretch.
In 2035, HROW is projected to trade between $128.66 and $307.90, averaging $191.19 — a potential gain of +393% from today's $38.77. That is up +23% on the projected 2034 average. Momentum favours further upside here.
Harrow, Inc.'s 2040 outlook centres on $269.64, within a $168.84 to $463.07 range. That is up +41% on the projected 2035 average. That marks a +595% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, HROW could reach as high as $1,342.25, with a base case around $711.97 and support toward $393.51 — roughly +17.4x from $38.77. Momentum favours further upside here.
Investing $1,000 in HROW today (≈ 25.793139 HROW) could be worth
$18,364.02
+$17,364.02 (+1736%) by 2050 · US Dollar
Based on the average projected HROW price of $711.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HROWwould be worth at today's price.
$1,000 invested in HROW on Jul 31, 2025 (≈ 31.486146 HROW) would be worth
$1,220.72
+$220.72 (+22.1%) today · 1.22× · US Dollar
Based on a HROW entry price of $31.76 vs. today's $38.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $38.45 | $1,008.32 | +0.8% |
| 1 month ago | $43 | $901.63 | -9.8% |
| 3 months ago | $40.9 | $947.92 | -5.2% |
| 6 months ago | $44.9 | $863.47 | -13.7% |
| 1 year ago | $31.76 | $1,220.72 | +22.1% |
| All time (5.0y) ago | $8.97 | $4,322.18 | +332.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HROW forecast.
Our base-case forecast reaches $78.00 around 2029.
Implied market cap at $78.00: $2.91B
The multi-year forecast shows a clear bullish arc, with the average price climbing steadily across the horizon. In 2027 the avg is $53.45 with a 39% ROI and a bullish sentiment, followed by 2028 at $70.50 (83.4% ROI) and 2029 at $88.75 (130.8% ROI).
By 2030 the avg is $109.46 with a 184.7% ROI, and by 2031 it is $122.44 with a 218.4% ROI. The path continues higher to 2032 at $127.93 (232.7% ROI), 2033 at $151.50 (294% ROI), 2034 at $176.66 (359.4% ROI), and 2035 at $218.06 (467.1% ROI).
Longer-horizon projections show substantial upside, with 2040 averaging $317.78 (726.5% ROI) and 2050 averaging $861.35 (2140.2% ROI). These figures reflect bullish expectations across the forecast curve, but they are estimates, not guarantees, and actual results can differ due to market dynamics and other factors.
Tap a question to reveal the answer.
Avg $109.46, min $81.57, max $158.18; ROI 184.7%; sentiment BULLISH.
Forecasts show a bullish path through 2027–2050, with rising avg prices and ROIs (e.g., 2027 avg $53.45; 2028 avg $70.50; 2029 avg $88.75; 2030 avg $109.46; 2040 avg $317.78; 2050 avg $861.35; ROI up to 2140.2%), but these are estimates, not guarantees.
Yes—the 2050 forecast max is $1,575.55, which would imply a large gain from the current price, corresponding to a 2140.2% ROI.
Current price $38.45; market cap $1.43B.
Min $29.03; avg $38.45; max $54.32; ROI 0; sentiment NEUTRAL.
Harrow, Inc. Community Discussion
0Share your Harrow, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.